HEADER TRANSFERASE 28-MAR-07 2PBF TITLE CRYSTAL STRUCTURE OF A PUTATIVE PROTEIN-L-ISOASPARTATE O- TITLE 2 METHYLTRANSFERASE BETA-ASPARTATE METHYLTRANSFERASE (PCMT) FROM TITLE 3 PLASMODIUM FALCIPARUM IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-L-ISOASPARTATE O-METHYLTRANSFERASE BETA-ASPARTATE COMPND 3 METHYLTRANSFERASE; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: RESIDUES 15-240; COMPND 6 EC: 2.1.1.77; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 GENE: PF14_0309; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: P15-LIC KEYWDS METHYLTRANSFERASE, PROTEIN REPAIR, ISOASPARTYL FORMATION, P. KEYWDS 2 FALCIPARUM, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.K.WERNIMONT,A.HASSANALI,L.LIN,J.LEW,Y.ZHAO,M.RAVICHANDRAN,G.WASNEY, AUTHOR 2 M.VEDADI,I.KOZIERADZKI,A.BOCHKAREV,A.M.EDWARDS,C.H.ARROWSMITH, AUTHOR 3 J.WEIGELT,M.SUNDSTROM,R.HUI,W.QIU,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 4 (SGC) REVDAT 5 30-AUG-23 2PBF 1 REMARK SEQADV REVDAT 4 18-OCT-17 2PBF 1 REMARK REVDAT 3 13-JUL-11 2PBF 1 VERSN REVDAT 2 24-FEB-09 2PBF 1 VERSN REVDAT 1 10-APR-07 2PBF 0 JRNL AUTH A.K.WERNIMONT,A.HASSANALI,L.LIN,J.LEW,Y.ZHAO,M.RAVICHANDRAN, JRNL AUTH 2 G.WASNEY,M.VEDADI,I.KOZIERADZKI,A.BOCHKAREV,A.M.EDWARDS, JRNL AUTH 3 C.H.ARROWSMITH,J.WEIGELT,M.SUNDSTROM,R.HUI,W.QIU JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE PROTEIN-L-ISOASPARTATE JRNL TITL 2 O-METHYLTRANSFERASE BETA-ASPARTATE METHYLTRANSFERASE (PCMT) JRNL TITL 3 FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH JRNL TITL 4 S-ADENOSYL-L-HOMOCYSTEINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 31337 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1673 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2278 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 124 REMARK 3 BIN FREE R VALUE : 0.3930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3476 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.46000 REMARK 3 B22 (A**2) : 1.46000 REMARK 3 B33 (A**2) : -2.19000 REMARK 3 B12 (A**2) : 0.73000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.216 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.188 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.175 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.398 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3582 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4832 ; 1.503 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 432 ; 6.484 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 154 ;38.433 ;25.325 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 696 ;16.646 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;23.120 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 566 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2580 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1845 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2434 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 229 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.243 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2246 ; 0.761 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3540 ; 1.309 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1502 ; 1.906 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1292 ; 2.870 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 9 A 227 5 REMARK 3 1 B 9 B 227 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 872 ; 0.05 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 863 ; 0.24 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 872 ; 0.29 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 863 ; 0.78 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2PBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000042191. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33234 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.89900 REMARK 200 R SYM FOR SHELL (I) : 0.71300 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1L1N REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.2 M (NH4)2SO4, 0.1 M REMARK 280 HEPES PH 7.2, 2 MM SAH, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.59267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 25.79633 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). AUTHORS STATE THAT THE REMARK 300 BIOLOGICAL UNIT OF THIS PROTEIN IS A MONOMER. REMARK 300 SEE REMARK 350 FOR INFORMATION ON GENERATING THE REMARK 300 BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ASN A 3 REMARK 465 MET A 4 REMARK 465 TYR A 5 REMARK 465 LYS A 6 REMARK 465 LEU A 7 REMARK 465 SER A 8 REMARK 465 LYS A 210 REMARK 465 GLY B 1 REMARK 465 ASN B 2 REMARK 465 ASN B 3 REMARK 465 MET B 4 REMARK 465 TYR B 5 REMARK 465 LYS B 6 REMARK 465 LEU B 7 REMARK 465 SER B 8 REMARK 465 LYS B 210 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 155 CD OE1 OE2 REMARK 470 ASP A 196 CG OD1 OD2 REMARK 470 GLU B 159 CD OE1 OE2 REMARK 470 ASP B 196 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 384 O HOH A 388 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 189 CA - CB - CG ANGL. DEV. = 15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 46 60.84 23.56 REMARK 500 ILE A 55 -66.65 -104.27 REMARK 500 SER A 56 166.67 175.81 REMARK 500 ASN A 186 -1.53 73.06 REMARK 500 ASP A 196 -101.31 54.67 REMARK 500 ASN A 208 -69.68 -134.59 REMARK 500 LEU A 216 -79.86 -90.05 REMARK 500 ILE B 46 60.86 26.53 REMARK 500 ILE B 55 -68.44 -104.37 REMARK 500 SER B 56 165.79 176.00 REMARK 500 GLU B 194 109.77 -53.06 REMARK 500 ASP B 196 -102.95 57.68 REMARK 500 ASN B 208 -78.47 -129.08 REMARK 500 LEU B 216 -77.26 -93.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 207 ASN A 208 148.48 REMARK 500 LYS B 207 ASN B 208 143.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 301 DBREF 2PBF A 2 227 UNP Q8ILD5 Q8ILD5_PLAF7 15 240 DBREF 2PBF B 2 227 UNP Q8ILD5 Q8ILD5_PLAF7 15 240 SEQADV 2PBF GLY A 1 UNP Q8ILD5 CLONING ARTIFACT SEQADV 2PBF GLY B 1 UNP Q8ILD5 CLONING ARTIFACT SEQRES 1 A 227 GLY ASN ASN MET TYR LYS LEU SER GLU ASN ASN HIS LYS SEQRES 2 A 227 SER LEU LEU GLU ASN LEU LYS ARG ARG GLY ILE ILE ASP SEQRES 3 A 227 ASP ASP ASP VAL TYR ASN THR MET LEU GLN VAL ASP ARG SEQRES 4 A 227 GLY LYS TYR ILE LYS GLU ILE PRO TYR ILE ASP THR PRO SEQRES 5 A 227 VAL TYR ILE SER HIS GLY VAL THR ILE SER ALA PRO HIS SEQRES 6 A 227 MET HIS ALA LEU SER LEU LYS ARG LEU ILE ASN VAL LEU SEQRES 7 A 227 LYS PRO GLY SER ARG ALA ILE ASP VAL GLY SER GLY SER SEQRES 8 A 227 GLY TYR LEU THR VAL CYS MET ALA ILE LYS MET ASN VAL SEQRES 9 A 227 LEU GLU ASN LYS ASN SER TYR VAL ILE GLY LEU GLU ARG SEQRES 10 A 227 VAL LYS ASP LEU VAL ASN PHE SER LEU GLU ASN ILE LYS SEQRES 11 A 227 ARG ASP LYS PRO GLU LEU LEU LYS ILE ASP ASN PHE LYS SEQRES 12 A 227 ILE ILE HIS LYS ASN ILE TYR GLN VAL ASN GLU GLU GLU SEQRES 13 A 227 LYS LYS GLU LEU GLY LEU PHE ASP ALA ILE HIS VAL GLY SEQRES 14 A 227 ALA SER ALA SER GLU LEU PRO GLU ILE LEU VAL ASP LEU SEQRES 15 A 227 LEU ALA GLU ASN GLY LYS LEU ILE ILE PRO ILE GLU GLU SEQRES 16 A 227 ASP TYR THR GLN VAL LEU TYR GLU ILE THR LYS LYS ASN SEQRES 17 A 227 GLY LYS ILE ILE LYS ASP ARG LEU PHE ASP VAL CYS PHE SEQRES 18 A 227 VAL SER LEU LYS LYS ASN SEQRES 1 B 227 GLY ASN ASN MET TYR LYS LEU SER GLU ASN ASN HIS LYS SEQRES 2 B 227 SER LEU LEU GLU ASN LEU LYS ARG ARG GLY ILE ILE ASP SEQRES 3 B 227 ASP ASP ASP VAL TYR ASN THR MET LEU GLN VAL ASP ARG SEQRES 4 B 227 GLY LYS TYR ILE LYS GLU ILE PRO TYR ILE ASP THR PRO SEQRES 5 B 227 VAL TYR ILE SER HIS GLY VAL THR ILE SER ALA PRO HIS SEQRES 6 B 227 MET HIS ALA LEU SER LEU LYS ARG LEU ILE ASN VAL LEU SEQRES 7 B 227 LYS PRO GLY SER ARG ALA ILE ASP VAL GLY SER GLY SER SEQRES 8 B 227 GLY TYR LEU THR VAL CYS MET ALA ILE LYS MET ASN VAL SEQRES 9 B 227 LEU GLU ASN LYS ASN SER TYR VAL ILE GLY LEU GLU ARG SEQRES 10 B 227 VAL LYS ASP LEU VAL ASN PHE SER LEU GLU ASN ILE LYS SEQRES 11 B 227 ARG ASP LYS PRO GLU LEU LEU LYS ILE ASP ASN PHE LYS SEQRES 12 B 227 ILE ILE HIS LYS ASN ILE TYR GLN VAL ASN GLU GLU GLU SEQRES 13 B 227 LYS LYS GLU LEU GLY LEU PHE ASP ALA ILE HIS VAL GLY SEQRES 14 B 227 ALA SER ALA SER GLU LEU PRO GLU ILE LEU VAL ASP LEU SEQRES 15 B 227 LEU ALA GLU ASN GLY LYS LEU ILE ILE PRO ILE GLU GLU SEQRES 16 B 227 ASP TYR THR GLN VAL LEU TYR GLU ILE THR LYS LYS ASN SEQRES 17 B 227 GLY LYS ILE ILE LYS ASP ARG LEU PHE ASP VAL CYS PHE SEQRES 18 B 227 VAL SER LEU LYS LYS ASN HET SAH A 301 26 HET SAH B 301 26 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 5 HOH *181(H2 O) HELIX 1 1 ASN A 11 ARG A 22 1 12 HELIX 2 2 ASP A 27 GLN A 36 1 10 HELIX 3 3 VAL A 37 TYR A 42 5 6 HELIX 4 4 ALA A 63 ILE A 75 1 13 HELIX 5 5 GLY A 92 MET A 102 1 11 HELIX 6 6 VAL A 118 LYS A 133 1 16 HELIX 7 7 PRO A 134 LYS A 138 5 5 HELIX 8 8 ASN A 148 VAL A 152 5 5 HELIX 9 9 ASN A 153 GLY A 161 1 9 HELIX 10 10 PRO A 176 LEU A 182 1 7 HELIX 11 11 ASN B 11 ARG B 22 1 12 HELIX 12 12 ASP B 27 GLN B 36 1 10 HELIX 13 13 VAL B 37 TYR B 42 5 6 HELIX 14 14 ALA B 63 ILE B 75 1 13 HELIX 15 15 GLY B 92 MET B 102 1 11 HELIX 16 16 VAL B 118 LYS B 133 1 16 HELIX 17 17 PRO B 134 ILE B 139 5 6 HELIX 18 18 ASN B 148 VAL B 152 5 5 HELIX 19 19 ASN B 153 GLY B 161 1 9 HELIX 20 20 PRO B 176 LEU B 182 1 7 SHEET 1 A 2 VAL A 53 SER A 56 0 SHEET 2 A 2 VAL A 59 ILE A 61 -1 O VAL A 59 N ILE A 55 SHEET 1 B 7 PHE A 142 HIS A 146 0 SHEET 2 B 7 TYR A 111 GLU A 116 1 N GLY A 114 O ILE A 145 SHEET 3 B 7 ARG A 83 VAL A 87 1 N ASP A 86 O LEU A 115 SHEET 4 B 7 PHE A 163 VAL A 168 1 O HIS A 167 N VAL A 87 SHEET 5 B 7 LEU A 183 GLU A 195 1 O ILE A 190 N ILE A 166 SHEET 6 B 7 THR A 198 THR A 205 -1 O ILE A 204 N LEU A 189 SHEET 7 B 7 ILE A 212 VAL A 219 -1 O VAL A 219 N GLN A 199 SHEET 1 C 2 VAL B 53 SER B 56 0 SHEET 2 C 2 VAL B 59 ILE B 61 -1 O VAL B 59 N ILE B 55 SHEET 1 D 7 PHE B 142 HIS B 146 0 SHEET 2 D 7 TYR B 111 GLU B 116 1 N GLY B 114 O ILE B 145 SHEET 3 D 7 ARG B 83 VAL B 87 1 N ALA B 84 O TYR B 111 SHEET 4 D 7 PHE B 163 VAL B 168 1 O HIS B 167 N VAL B 87 SHEET 5 D 7 LEU B 183 GLU B 195 1 O ILE B 190 N ILE B 166 SHEET 6 D 7 THR B 198 THR B 205 -1 O ILE B 204 N LEU B 189 SHEET 7 D 7 ILE B 212 VAL B 219 -1 O VAL B 219 N GLN B 199 SITE 1 AC1 24 VAL A 59 THR A 60 ILE A 61 SER A 62 SITE 2 AC1 24 HIS A 67 GLY A 88 SER A 89 GLY A 90 SITE 3 AC1 24 SER A 91 GLU A 116 ARG A 117 VAL A 118 SITE 4 AC1 24 LYS A 147 ASN A 148 ILE A 149 GLY A 169 SITE 5 AC1 24 VAL A 222 SER A 223 LEU A 224 LYS A 225 SITE 6 AC1 24 HOH A 305 HOH A 315 HOH A 319 HOH A 379 SITE 1 AC2 24 VAL B 59 THR B 60 ILE B 61 SER B 62 SITE 2 AC2 24 HIS B 67 GLY B 88 SER B 89 GLY B 90 SITE 3 AC2 24 SER B 91 GLU B 116 ARG B 117 VAL B 118 SITE 4 AC2 24 LYS B 147 ASN B 148 ILE B 149 GLY B 169 SITE 5 AC2 24 VAL B 222 SER B 223 LEU B 224 LYS B 225 SITE 6 AC2 24 HOH B 307 HOH B 317 HOH B 321 HOH B 379 CRYST1 75.156 75.156 77.389 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013306 0.007682 0.000000 0.00000 SCALE2 0.000000 0.015364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012922 0.00000